Research Article
Syntheses of Isoxazoline-Carbocyclic Nucleosides and Their Antiviral Evaluation: A Standard Protocol
Table 1
Tautomeric ratios and chemical shifts for compounds 14a,bS.
| Solvent | I/II | CH=N | Ha | Hb | Hc | Hd | He |
| | | | CD3COCD3 | 1/1.5 | (I) 8.23, 8.44 | 4.61 | 5.73 | 4.49 | 5.18 | 2.59 | (II) 8.78, 8.83 | 4.64 | 5.81 | 4.54 | 5.31 | 2.65 | DMSO-d6 | 4/1 | (I) 8.14, 8.43 | 4.30 | 5.62 | 4.26 | 5.00 | 2.38 | (II) 8.80, 8.81 | 4.30 | 5.74 | 4.26 | 5.19 | 2.45 | CD3OD | 1/1 | (I) 8.15, 8.50 | 4.90 | 5.60 | 4.45 | 5.16 | 2.45 | (II) 8.78, 8.82 | 4.90 | 5.75 | 4.40 | 5.27 | 2.45 |
| | | | CD3COCD3 | 2/1 | (I) 8.25, 8.34 | 4.62 | 5.75 | 4.45 | 5.15 | 2.50 | (II) 8.75, 8.78 | 4.62 | 5.76 | 4.50 | 5.25 | 2.58 | DMSO-d6 | 1/1 | (I) 8.84, 8.87 | 4.34 | 5.71 | 4.34 | 5.11 | 2.41 | (II) 8.24, 8.48 | 4.34 | 5.61 | 4.34 | 5.95 | 2.32 | CD3OD | 1/1.5 | (I) 8.81, 8.85 | 4.48 | 5.76 | 4.48 | 5.29 | 2.50 | (II) 8.18, 8.50 | 4.48 | 5.67 | 4.48 | 5.16 | 2.50 |
|
|